Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study

Akihito Kawazoe(National Cancer Center Hospital East), Reinhard Depenbusch(Rambam Health Care Campus), Matthew Burge(Royal Brisbane and Women's Hospital), Luciana Bella Quero, Kai‐Keen Shiu(University College London Hospitals NHS Foundation Trust), Camilla Qvortrup(Copenhagen University Hospital), Sebastian Stintzing(Humboldt-Universität zu Berlin), Volker Heinemann(LMU Klinikum), Maria Passhak(Rambam Health Care Campus), Elena Élez(Vall d'Hebron Hospital Universitari), Hongming Pan, Kathryn Towns(North York General Hospital), Lars Henrik Jensen(Sorbonne Université), Ezequiel Slutsky, Peter Gibbs(The University of Melbourne), Stefan Kubicka(Medizinische Hochschule Hannover), Dirk Arnold(Asklepios Klinik Altona), Brandon M. Meyers(North York General Hospital), Félix Couture, Luis Fein(National Cancer Center), Timothy Price(Basil Hetzel Institute), Takayuki Yoshino(University of Tsukuba), Lucas Sidéris(McGill University Health Centre), Per Pfeiffer(University of Southern Denmark), Hao‐Wei Teng(National Yang Ming Chiao Tung University), Rishi Jain(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael B. Sawyer(University of Alberta), Ardaman Shergill(University of Chicago), David E. Adelberg(Merck & Co., Inc., Rahway, NJ, USA (United States)), A. A. Lebedinets(Leningrad Regional Cancer Center), Julieta Grasselli, Warren Joubert, Pilar García‐Alfonso(Hospital General Universitario Gregorio Marañón), Rong Fu(Tianjin Medical University General Hospital), Tae Won Kim(Asan Medical Center), Rui‐Hua Xu(Sun Yat-sen University), Bruce Colwell, Muhammad A. Khattak, Sumitra Ananda(Royal Women's Hospital), Juan Cundom, Sylvie Lorenzen(Technical University of Munich), Wei Wang(Shanghai Medical College of Fudan University), Mahmut Gümüş(Istanbul Medeniyet University)
Journal of Clinical Oncology
June 4, 2024
Cited by 77


Related Papers